financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Matador Resources Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Matador Resources Company
Apr 25, 2024 6:26 AM

09:05 AM EDT, 04/25/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target of $68, up $4, reflects a 5.9x multiple of EV to projected 2024 EBITDA, above MTDR's historical average. We think a premium is merited due to MTDR's sub-1.0x net debt-to-EBITDA ratio (0.75x). We lift our 2024 EPS view by $0.41 to $7.34 and 2025's by $0.85 to $7.89. Q1 EPS of $1.71 vs. $1.50, beat consensus by $0.16. Q1 revenue (~$788M) rose 41% Y/Y, driven by sales of purchased natural gas (+44%). Production (~150k boe/d) grew 40% Y/Y due to robust crude oil volumes (+44%). As a result, MTDR revised its 2024 production guide, with production now expected to be at the high end of its prior outlook (153k-159k boe/d vs. 131k boe/d in 2023), while keeping its capex guide intact (midpoint of $1.4B vs. $1.3B in 2023). However, we think MTDR's 2024 expectations might be too aggressive (+20% Y/Y production growth; +8% capex growth), given that its peers, by our estimation, are keeping their 2024 production levels flat from 2023 while reducing their capex spending by around 9%. Shares yield 1.2%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lowers Opinion On Shares Of Globus Medical To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of Globus Medical To Hold From Buy
Nov 24, 2025
10:25 AM EST, 11/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $20 to $90, based on 22.5x our FY 26 EPS estimate and in line with the company's three-year average forward P/E multiple. We...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Analog Devices
Research Alert: CFRA Maintains Buy Opinion On Shares Of Analog Devices
Nov 25, 2025
12:40 PM EST, 11/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to $280 from $265, based on a P/E of 25x our CY 2027 EPS forecast of $11.20, within historical and peer averages. Based on...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Nio Inc.
Research Alert: CFRA Keeps Hold Opinion On Adss Of Nio Inc.
Nov 25, 2025
12:55 AM EST, 11/26/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our unchanged target price of USD6.50 implies a 2026 P/S of 1.0x (five-year mean: 3.9x), based on our projected slower revenue growth (vs. five-year revenue CAGR through 2024). We project...
Research Alert: CFRA Raises Opinion On Shares Of Crown Holdings, Inc. To Strong Buy From Buy
Research Alert: CFRA Raises Opinion On Shares Of Crown Holdings, Inc. To Strong Buy From Buy
Nov 25, 2025
12:50 PM EST, 11/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target at $128 on an EV/EBITDA of 9.2x our 2026 EBITDA estimate, below its five-year average of 9.5x. We keep our 2025 EPS view at $7.97...
Copyright 2023-2026 - www.financetom.com All Rights Reserved